FMP
Oct 8, 2021 5:02 PM - Davit Kirakosyan
Analysts at Berenberg Bank provided their outlook on Merck & Co., Inc. (NYSE:MRK), increasing their price target on the company’s shares to $92 from $86, while maintaining their hold rating.
The price target change was due to a 4-10% increase in the brokerage’s EPS forecasts, which was based on (1) positive data for molnupiravir in COVID-19 treatment, (2) a reduction in Pneumovax/Vaxneuvance sales, more than offset by an increase in Gardasil sales, and (3) the Acceleron acquisition.
While the analysts said they are overall encouraged by the positive direction of travel, they believe more steps are needed to overcome the concentration risk of Keytruda (46% of NPV), with Keytruda adjuvant and/or combination studies’ risk of failure or competitors’ reaching of the market sooner.
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Oct 17, 2023 3:09 PM - Davit Kirakosyan
Shares of VMware (NYSE:VMW) witnessed a sharp drop of 12% intra-day today due to rising concerns about China's review of the company's significant sale deal to Broadcom. Consequently, Broadcom's shares also saw a dip of around 4%. Even though there aren’t any apparent problems with the proposed solu...